Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
The University of Würzburg has shed light on the intricate mechanisms of insulin production in fruit flies, revealing surprising parallels with human physiology. This study offers crucial insights into how insulin-producing cells respond to metabolic changes, with potential implications for understanding and treating diabetes.
Scientists have created an 'artificial pancreas' that uses an algorithm to protect the body - especially ground-breaking for young children with type 1 diabetes.
Claire Kendal-Wright, PhD, from Chaminade University of Honolulu, argues that when it comes to understanding the normal human parturition mechanisms, danger associated molecular patterns may be part of the answer.
Glooko reveals how remote patient monitoring technologies to manage diabetes and related chronic conditions are delivering long-term benefits and will likely become part of standard at-home care management.
South Asians have the highest rate of type 2 diabetes in the UK, due to a mix of racial and socioeconomic factors - now, researchers say that a more nuanced method of classifying race could improve their health outcomes.
According to a Californian study, people over the age of 40 with type 1 diabetes are likely to experience severe COVID - leading to hospitalisation or death.
Tess Player, VP, Global Head of Expert and Influence Marketing, GSK Consumer Healthcare, discusses how low public understanding of oral health is symptomatic of the need for better everyday health education.
Riceberry rice, enriched with a full-spectrum of antioxidants, chemoprotective compounds, micronutrients, and dietary fibre can help unlock your genetic potential for well-being, in the view of Professor Dr Apichart Vanavichit, Director at the Rice Science Center in Thailand.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that the rice crop is a vital cog in ensuring food security
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
